Spacelabs Medical Enhances Wireless Options, Connectivity

Spacelabs Medical, a global leader in patient monitoring systems, announced the availability of a wireless networking option for its UltraviewSL compact monitors.  As part of the companys commitment to open standards and connectivity, Spacelabs has developed a wireless solution that is capable of operating on a hospitals existing wireless infrastructure while coexisting with other wireless applications.  Spacelabs is initially launching its wireless connectivity solution in the US and Canada; worldwide distribution is planned for early 2006.



Designed to meet customer needs for ease of use and compatibility with global standards, the UltraviewSL 2400 wireless monitor is compliant with 802.11b, the WiFi standard that has gained broad acceptance within health care institutions worldwide.  Spacelabs is also introducing a field upgrade kit to enable existing UltraviewSL compact monitors to operate in a wireless environment.



In patient transport, when surveillance of critically ill patients may be most challenging, wireless connectivity is particularly important.  By employing wireless monitoring, vital signs data can be displayed and viewed on central monitors while patients are being moved, enhancing patient safety and emergency response capabilities.  In addition, wireless connectivity allows for continued, seamless collection of patient data into Spacelabs Intesys Clinical Suite (ICS) of network applications, helping minimize interruptions in automated documentation.





According to David Tilley, President and COO of Spacelabs Medical, The Spacelabs vision of open standards and connectivity has taken another step forward with the introduction of a wireless network option for the UltraviewSL 2400.  Wireless network capability enables clinicians to access and document real-time patient information even during transport, helping them make critical decisions quickly and seamlessly.



The UltraviewSL 2400 wireless monitor provides a flexible solution that enables hospitals to augment the number of networked bedside monitors when extra capacity is needed.  The new monitor has full network compatibility with all existing Spacelabs UltraviewSL, Ultraview and PCMS centrals and bedside monitors.

About Spacelabs Medical

Spacelabs Medical (www.spacelabs.com), based in Issaquah, WA, U.S., is a global manufacturer and distributor of patient monitoring systems for critical care and anesthesia, wired and wireless networks and clinical information connectivity solutions, ambulatory blood pressure (ABP) monitors and medical data services.  It has sold approximately 117,000 patient monitoring units worldwide.  Spacelabs has distribution partnerships in approximately 80 countries and sales or regional offices throughout the world and employs approximately 800 employees.


Spacelabs Medical is a division of Spacelabs Healthcare, Inc., a publicly listed company on the AIM in London.

About Spacelabs Healthcare, Inc.

Spacelabs Healthcare, Inc. is an international developer, manufacturer and distributor of medical equipment and services including patient monitoring solutions, anesthesia delivery and ventilation systems, pulse oximeters and sensors and bone densitometers selling to hospitals, clinics and physicians offices.  Additionally, the company provides ECG laboratory services to pharmaceutical companies undertaking clinical trials, whereby patient ECG data is recorded, analyzed, tabulated and interpreted.

The company has established brand names in both medical devices and medical services such as Spacelabs, Blease and Dolphin.  The company employs approximately 1,050 personnel in its 14 offices in UK, Canada, France, Germany, Finland, Singapore and the United States. The company conducts its manufacturing and R&D in India, the UK and the United States.



Spacelabs Healthcare is a subsidiary of OSI Systems, Inc., a US-based, Nasdaq listed company.

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding our expectations, goals or intentions about the future, including, but not limited to, statements regarding the sale, distribution and use of UltraviewSL compact monitors. The actual results may differ materially from those described in or implied by any forward-looking statement. Other important factors are set forth in our Securities and Exchange Commission filings. All forward-looking statements speak only as of the date made, and we undertake no obligation to update these forward-looking statements.

Contact:
Tiina Tukia   
Spacelabs Medical
Tiina.tukia@slmd.com